262 results on '"King, Jordan B."'
Search Results
2. Impact of Self‐Monitoring of Blood Pressure on Processes of Hypertension Care and Long‐Term Blood Pressure Control
3. Clinic-Based Strategies to Reach United States Million Hearts 2022 Blood Pressure Control Goals
4. Abstract 13622: Association Between Self-Reported Medication Adherence and Therapeutic Inertia in Hypertension: A Secondary Analysis of the Systolic Blood Pressure Intervention Trial (SPRINT)
5. Factors associated with antihypertensive monotherapy among US adults with treated hypertension and uncontrolled blood pressure overall and by race/ethnicity, National Health and Nutrition Examination Survey 2013-2018
6. Race/ethnic and sex differences in the initiation of non-statin lipid-lowering medication following myocardial infarction
7. Abstract 11668: Trends in Statin Use for Primary Prevention by Race/Ethnicity and ASCVD Risk in the US: 2013-2020
8. Diagnostic Accuracy and Time-Saving Effects of Point-of-Care Ultrasonography in Patients With Small Bowel Obstruction: A Prospective Study
9. The role of clinical pharmacy anticoagulation services in direct oral anticoagulant monitoring
10. Multiple Social Vulnerabilities to Health Disparities and Hypertension and Death in the REGARDS Study
11. Association Between Self‐Reported Medication Adherence and Therapeutic Inertia in Hypertension: A Secondary Analysis of SPRINT (Systolic Blood Pressure Intervention Trial)
12. Clinical and Economic Outcomes of Ranolazine Versus Conventional Antianginals Users Among Veterans With Chronic Stable Angina Pectoris
13. Pharmacokinetics of Continuous Infusion Beta-lactams in the Treatment of Acute Pulmonary Exacerbations in Adult Patients With Cystic Fibrosis
14. Trends in high-intensity statin use and low-density lipoprotein cholesterol control among patients enrolled in a clinical pharmacy cardiac risk service
15. Cost-Effectiveness of Treatment Options for Neuropathic Pain: a Systematic Review
16. Glucagon-like peptide-1 receptor agonist and sodium-glucose cotransporter 2 inhibitor use among adults with diabetes mellitus by cardiovascular-kidney disease risk: National Health and Nutrition Examination Surveys, 2015-2020
17. Left atrial fibrosis is associated with new-onset heart failure in patients with atrial fibrillation
18. Fixed-Dose Combination Medications for Treating Hypertension: A Review of Effectiveness, Safety, and Challenges
19. Abstract 16486: Consistent Cost-effectiveness of Icosapent Ethyl Across Patient Profiles From REDUCE-IT
20. Abstract 15272: Estimating Life Expectancy of Systolic Blood Pressure Intervention Trial Participants Using Pooled Epidemiologic Cohort Data
21. Abstract 15256: Predicting Out-of-office Blood Pressure in United States Adults
22. Trends in Antihypertensive Medication Monotherapy and Combination Use Among US Adults, National Health and Nutrition Examination Survey 2005–2016
23. New Users of Angiotensin II Receptor Blocker–Versus Angiotensin‐Converting Enzyme Inhibitor–Based Antihypertensive Medication Regimens and Cardiovascular Disease Events: A Secondary Analysis of ACCORD‐BP and SPRINT
24. Single-Pill Combination Product Availability of the Antihypertensive Regimens Used for Intensive Systolic Blood Pressure Treatment in the Systolic Blood Pressure Intervention Trial
25. Association of Direct Oral Anticoagulation Management Strategies With Clinical Outcomes for Adults With Atrial Fibrillation
26. Glucagon-like peptide-1 receptor agonist and sodium-glucose cotransporter 2 inhibitor use among adults with diabetes mellitus by cardiovascular-kidney disease risk: National Health and Nutrition Examination Surveys, 2015–2020
27. Exercise Capacity Correlates With Left Atrial Structural Remodeling as Detected by Late Gadolinium-Enhanced Cardiac Magnetic Resonance in Patients With Atrial Fibrillation
28. Cost-Effectiveness of Sacubitril-Valsartan Combination Therapy Compared With Enalapril for the Treatment of Heart Failure With Reduced Ejection Fraction
29. Annual Cost of Implementing Intensive Systolic Blood Pressure Goals in the United States.
30. Characteristics and Healthcare Utilization Among Veterans Treated for Heart Failure With Reduced Ejection Fraction Who Switched to Sacubitril/Valsartan
31. Association of Total Medication Burden With Intensive and Standard Blood Pressure Control and Clinical Outcomes: A Secondary Analysis of SPRINT
32. Cost-Effectiveness and Challenges of Implementing Intensive Blood Pressure Goals and Team-Based Care
33. Effectiveness of Hypertension Management Strategies in SPRINT-Eligible US Adults: A Simulation Study.
34. Identifying Patients for Intensive Blood Pressure Treatment Based on Cognitive Benefit
35. Antihypertensive Medication Regimens Used by US Adults With Hypertension and the Potential for Fixed‐Dose Combination Products: The National Health and Nutrition Examination Surveys 2015 to 2020
36. 2020 - Derington et al - Twice-daily versus once-daily lisinopril and losartan for hypertension- Real-world effectiveness and safety.pdf
37. Prevalence of Statin Use for Primary Prevention of Atherosclerotic Cardiovascular Disease by Race, Ethnicity, and 10-Year Disease Risk in the US
38. Antihypertensive Medication Regimens Used in the Systolic Blood Pressure Intervention Trial
39. Durable lesion formation while avoiding esophageal injury during ablation of atrial fibrillation: Lessons learned from late gadolinium MR imaging
40. Cost-Effectiveness of Masked Hypertension Screening and Treatment in US Adults With Suspected Masked Hypertension: A Simulation Study
41. Abstract 170: Cost-effectiveness Of Icosapent Ethyl In Reduce-it USA: Results From Patients Randomized In The United States
42. Cost-effectiveness of Icosapent Ethyl for High-risk Patients With Hypertriglyceridemia Despite Statin Treatment
43. Predicting Out-of-Office Blood Pressure in a Diverse US Population
44. Analysis of Therapeutic Inertia and Race and Ethnicity in the Systolic Blood Pressure Intervention Trial: A Secondary Analysis of a Randomized Clinical Trial
45. Factors Associated with Antihypertensive Monotherapy Among US Adults with Treated Hypertension and Uncontrolled Blood Pressure Overall and by Race/Ethnicity, NHANES 2013–2018
46. Pharmacotherapy Treatment Patterns, Outcomes, and Health Resource Utilization Among Patients with Heart Failure with Reduced Ejection Fraction at a U.S. Academic Medical Center
47. Neprilysin Inhibition in Heart Failure with Reduced Ejection Fraction: A Clinical Review
48. Sacubitril/Valsartan Initiation Among Veterans Who Are Renin‐Angiotensin‐Aldosterone System Inhibitor Naïve With Heart Failure and Reduced Ejection Fraction
49. Temporal trends in first-line outpatient anticoagulation treatment for cancer-associated venous thromboembolism
50. Estimating Systolic Blood Pressure Intervention Trial Participant Posttrial Survival Using Pooled Epidemiologic Cohort Data
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.